A systematic review and meta-analysis of diagnostic delay in pulmonary embolism

por van Maanen, R., Trinks-Roerdink, E. M., Rutten, F. H., Geersing, G. J.
Publicado 2022

Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a change

por Boonman-de Winter, L. J. M., Cramer, M. J., Hoes, A. W., Rutten, F. H.
Publicado 2016

Management of superficial venous thrombosis based on individual risk profiles: protocol for the development and validation of three prognostic prediction models in large primary ca...

por van Royen, F. S., van Smeden, M., Moons, K. G. M., Rutten, F. H., Geersing, G. J.
Publicado 2021

The effects of misclassification in routine healthcare databases on the accuracy of prognostic prediction models: a case study of the CHA2DS2-VASc score in atrial fibrillation

por van Doorn, S., Brakenhoff, T. B., Moons, K. G. M., Rutten, F. H., Hoes, A. W., Groenwold, R. H. H., Geersing, G. J.
Publicado 2017

Training general practitioners to improve evidence-based drug treatment of patients with heart failure: a cluster randomised controlled trial

por Valk, M. J. M., Hoes, A. W., Mosterd, A., Landman, M. A., Zuithoff, N. P. A., Broekhuizen, B. D. L., Rutten, F. H.
Publicado 2020

Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directions

por van Ommen, A. M. L. N., Canto, E. Dal, Cramer, Maarten J., Rutten, F. H., Onland-Moret, N. C., Ruijter, H. M. den
Publicado 2022

Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men

por Buddeke, J., Valstar, G. B., van Dis, I., Visseren, F. L. J., Rutten, F. H., den Ruijter, H. M., Vaartjes, I., Bots, M. L.
Publicado 2020

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020

por Chu, G., Seelig, J., Trinks-Roerdink, E. M., Geersing, G. J., Rutten, F. H., de Groot, J. R., Huisman, M. V., Hemels, M. E. W.
Publicado 2020

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community

por Joosten, L. P. T., de Boer, A. R., van Eerde, E. J. B., van Doorn, S., Hoes, A. W., Bots, M. L., Rutten, F. H., Geersing, G. J.
Publicado 2022

High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes

por Boonman-de Winter, L. J. M., Rutten, F. H., Cramer, M. J. M., Landman, M. J., Liem, A. H., Rutten, G. E. H. M., Hoes, A. W.
Publicado 2012

Heart failure with preserved ejection fraction in women: the Dutch Queen of Hearts program

por den Ruijter, H., Pasterkamp, G., Rutten, F. H., Lam, C. S. P., Chi, C., Tan, K. H., van Zonneveld, A. J., Spaanderman, M., de Kleijn, D. P. V.
Publicado 2015

Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial

por Trinks-Roerdink, E M, Geersing, G J, Van Den Dries, C J, Rutten, F H, Hemels, M E W, Rienstra, M, Van Smeden, M, Van Klaveren, D, Kent, D M, Van Doorn, S
Publicado 2023

Neutrophil and Eosinophil Responses Remain Abnormal for Several Months in Primary Care Patients With COVID-19 Disease

por Jukema, B. N., Smit, K., Hopman, M. T. E., Bongers, C. C. W. G., Pelgrim, T. C., Rijk, M. H., Platteel, T. N., Venekamp, R. P., Zwart, D. L. M., Rutten, F. H., Koenderman, L.
Publicado 2022

Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation

por Seelig, J, Trinks-Roerdink, E M, Chu, G, Pisters, R, Theunissen, L J H J, Trines, S A, Pos, L, Kirchhof, C J H J, de Jong, S F A M S, den Hartog, F R, van Alem, A P, Polak, P E, Tieleman, R G, van der Voort, P H, Lenderink, T, Otten, A M, de Jong, J S S G, Gu, Y L, Luermans, J G L M, Kruip, M J H A, Timmer, S A J, de Vries, T A C, Cate, H ten, Geersing, G J, Rutten, F H, Huisman, M V, Hemels, M E W
Publicado 2022